Study Identifies Possible New Target for Future Brain Cancer Drugs
Glioblastoma multiforme (GBM) is a lethal brain cancer that has an average survival of 15 months, so there is a critical need for new treatments.
This study found that GBM tumors that have high lev
Study of ‘Super Responder’ Reveals Possible New Gene Target for Lung Cancer
COLUMBUS, Ohio — A potential new gene mutation that might drive lung cancer development and growth has been identified by researchers at The Ohio State University Comprehensive Cancer Center – Arthur
Addition of Bevacizumab to the Treatment of Newly Diagnosed Glioblastoma Brain Tumors Does Not Extend Patients’ Lives
COLUMBUS, Ohio – Results from a randomized, phase 3 clinical trial conducted by the Radiation Therapy Oncology Group (RTOG) have shown that adding bevacizumab, a drug that inhibits the growth of blood
Ohio State Cancer Research Played a Significant Role in FDA Approval of Important New CLL Drug
COLUMBUS, Ohio – On Feb. 12, 2014, the U.S. Food and Drug Administration expanded the approved use of the drug ibrutinib to chronic lymphocytic leukemia (CLL).
Much of the clinical and basic-scienc
Study Reveals How Cancer Cells Thrive in Oxygen-Starved Tumors
Growing tumors often have areas of low oxygen, a condition called hypoxia.
How cancer cells survive and thrive under the stress of hypoxia is poorly understood.
This study shows how cancer cells cha
Yoga Can Lower Fatigue, Inflammation in Breast Cancer Survivors
In study, the more
women practiced, the better their results
COLUMBUS, Ohio -- Practicing yoga for as little as three months can reduce fatigue and lower in
Number of Cancer Stem Cells Might Not Predict Outcome in HPV-Related Oral Cancers
COLUMBUS, Ohio – New research from The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) suggests that it ma
Ohio State Awarded $11.3 Million for Thyroid Cancer Research
Prestigious National Cancer Institute SPORE grant third for cancer center
COLUMBUS, Ohio –The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital
AML Score That Combines Genetic and Epigenetic Changes Might Help Guide Therapy
Guido Marcucci, MD
Currently, treatments for adult acute myeloid leukemia (AML) are determined mainly using the chromosome changes and gene mutations present in AML cells.
In this study, researchers
Laboratory Study Confirms Target of Potent Chronic Leukemia Drug
Jennifer Woyach, MD
The experimental drug ibrutinib can be exceptionally effective in treating chronic leukemia, but it is unclear whether its primary target, a molecule called BTK, is important for
Tomato-Rich Diet Increases Hormone Linked to Reduced Breast Cancer Risk in Postmenopausal Women
COLUMBUS, Ohio – A tomato-rich diet could help protect at-risk postmenopausal women from breast cancer, according to new research from The Ohio State University Comprehensive Cancer Center – Arthur G.
Pelotonia Riders Pedal to a Record $19 Million for Cancer Research
Fundraising total of $61 million for first five years
COLUMBUS, Ohio - Pelotonia has announced record fundraising of more than $19 million for its 2013 ride.
From August 10-11, 2013, 6,723
Nine More Big Ideas in Cancer Research at Ohio State Funded by Pelotonia
COLUMBUS, OHIO—New treatments that target markers in individual cancers; packaging a novel leukemia drug in nano-sized bubbles of fat; and a national cancer disparities research network are among the
Next-Generation Genome Screening Is Step Toward Precision Cancer Medicine for Lung Cancer
DNA analysis helps doctors identify drugs to more precisely target individual patient tumors
COLUMBUS, Ohio – Precision cancer medicine has taken a strong step forward at the Ohio State Universi
HPV Can Damage Genes and Chromosomes Directly, Sequencing Study Shows
Maura Gillison, MD, PhD
Human papillomavirus (HPV) causes cervical, head and neck, anal and other cancers.
How it causes cancer isn’t completely known.
This study shows that HPV can damage genes a
Ohio State Trial Tests Novel Two-Drug Combination for Triple Negative Breast Cancers
COLUMBUS, Ohio -- Breast cancer researchers at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital & Richard J. Solove Research Institute (OSUCCC – James) are test
Genomic Medicine Pioneer to Present Annual Block Lecture at Ohio State
COLUMBUS, Ohio – Eric S. Lander, PhD, president and founding director of the Broad Institute of the Massachusetts Institute of Technology and Harvard University, will receive the 20th annual Herbert a
Cancer Wasting Due in Part to Tumor Factors That Block Muscle Repair, Study Shows
Cancer wasting causes 20-25 percent of cancer deaths.
Tumor growth causes the condition, which has no treatment.
This study shows that cancer wasting is due in part to tumor factors that block muscl
Ohio State Testing a New Spice Derivative Formulation for Breast Cancer Prevention
COLUMBUS, Ohio – A clinical trial at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) investigates wh
Minimally Invasive Surgery Helps Young Cancer Patients Maintain Fertility
COLUMBUS, Ohio – Although the human papillomavirus (HPV) vaccine, pap smears and increased public awareness have reduced cervical cancer rates in the United States, the disease still affects at least